向瘤微环境中的髓质衍生抑制细胞:对于骨髓瘤的潜在治疗方法
Hye In Ka1, Se Hwan Mun1, Sora Han1
1Research Institute of Women's Health, Sookmyung Women's University, Seoul, 04312, Republic of Korea.
Oncology research
|March 20, 2025
概括
骨髓系衍生抑制细胞 (MDSCs) 在骨髓瘤患者中升高,促进瘤生长. 针对MDSC提供了一个有希望的治疗策略,以改善患者的治疗结果和生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓瘤是一种具有复杂瘤微环境的侵袭性骨癌.
- 免疫细胞不平衡,特别是肌髓衍生抑制细胞 (MDSCs) 的增加,与骨髓瘤的进展和转移有关.
研究的目的:
- 审查MDSCs在骨髓瘤中的作用.
- 讨论针对MDSC的治疗策略,以改善患者预后.
主要方法:
- 关于骨髓瘤和MDSCs的研究的文献综述.
- 临床数据和动物模型的分析.
主要成果:
- 在骨髓瘤患者的外周血液中观察到较高的MDSC水平.
- MDSCs表现出免疫抑制和促癌作用,促进瘤扩散和转移.
- 介素18水平与骨髓瘤模型中的MDSC水平相关.
结论:
- MDSCs在骨髓瘤的发病过程中发挥着至关重要的作用.
- 准MDSC是一种有前途的治疗途径,用于骨髓瘤治疗.
- 旨在减少MDSC的干预措施可以提高患者的生存率和预后.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


